Benefiting These Issues...
Benefits of Neurotherapy with ADD-ADHD
Attention Deficit Disorder (ADD) and Attention Deficit Hyperactivity Disorder (ADHD) are the most common neurobehavioral disorders of childhood, but do occur in adults as well. Individuals living with ADD/ADHD can be characterized as having an impaired ability to regulate their activity level (hyperactivity), impaired focus and concentration (inattention), and an inability to inhibit their behavior (impulsivity). Individuals with ADD/ADHD often have problems in emotional flexibility; many are diagnosed with underlying anxiety or depression.
Neurotherapy studies suggest that the brains of children and adults with ADD/ADHD are different from those of the average population. Brain Mappings (QEEG) of people with ADD/ADHD display a disproportionate amount of slow brain waves in the anterior and central areas of the brain. These areas of slow brain waves are associated with being spacey and disengaged to being fidgety and easily distracted to showing poor judgment and impulse control. There is no proven way to prevent ADD/ADHD, but with early identification and treatment many of the problems associated with ADD/ADHD can be decreased. The Brain & Life Renewal Center uses multiple approaches such as 19 channel Z-score LORETA Neurofeedback to help retrain the brain for optimal function and performance.
Patient’s have reported a significant decrease in the presenting symptoms of ADD/ADHD. Patients have reported that they are more focused, organized, calm, and are performing better in school and/or work. Parents report that their children have begun to hand in homework on time, require less supervision in completing tasks, have better impulse control, and feel more self-confident in social activities.
Resources on the Benefits of Neurotherapy and ADD-ADHD
Alhambra, M. A., Fowler, T. P., & Alhambra, A. A. (1995). EEG biofeedback: A new treatment option for ADD/ADHD. Journal of Neurotherapy, 1(2), 39–43.
Arns, M. (2012). EEG-based personalized medicine in ADHD: Individual alpha peak frequency as an endophenotype associated with nonresponse. Journal of Neurotherapy.
Arns, M, de Ridder, S, Strehl, U, Breteler, M, & Coenen, A. (2009). Efficacy of neurofeedback treatment in ADHD: The effects on inattention, impulsivity and hyperactivity: A meta-analysis. Clinical EEG and Neuroscience, 40(3) 180–189.
Arns, M, Feddema, I, & Kenemans, J. (2014) Differential effects of Theta/Beta and SMR neurofeedback in ADHD on sleep onset latency. Frontiers in Human Neuroscience 8:1019. doi:10.3389/fnhum.2014.01019
Barabasz, A., & Barabasz, M. (1996). Neurotherapy and alert hypnosis in the treatment of attention deficit disorder. Chapter in S. J. Lynn, I. Kirsch, & J. W. Rhue (Eds.), Casebook of Clinical Hypnosis. Washington, D.C.: American Psychological Association Press, 271–292.